INDP - Wutah pendapatan taunan sajrone rolas wulan kepungkur Indaptus Therapeutics

Indaptus Therapeutics (INDP) minimizes oncological risks by implementing universal immunotherapy methods based on attenuated bacteria. The TTM annual revenue trend captures these processes, where 0.00 serves as the current parameter value. The company's growth relies on clinical trials of the decOyp platform and M&A potential, while product relevance is confirmed by the development of methods to combat solid tumors.
Ringkesan rincian data analitis Indaptus Therapeutics (INDP)

This indicator measures the percentage change in aggregate revenue over a rolling twelve-month period, promptly capturing real shifts in consumer demand without market noise. By analyzing the LTM sales growth YoY, an investor assesses the commercial efficiency of Indaptus Therapeutics (INDP), whose positions in oncology rely on unique immune activation methods and a high degree of trust from the specialized medical community.